---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024802"
form_type: "8-K"
ticker: "ONMD"
cik: "0001849380"
company_name: "OneMedNet Corp"
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:58:57.915354+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OneMedNet enters $25M equity line and $1.5M convertible note with Yorkville; terminates prior $4.54M deal

## Summary
- Up to $25M standby equity purchase agreement with Yorkville; purchases at 97% of Market Price; 24-month term; subject to conditions.
- $1.5M convertible promissory note from Yorkville; 0% interest (18% default); convertible at lower of $1.3408 fixed or 90% of 7-day VWAP (floor $0.28).
- Terminated $4.54M convertible note deal with Helena Global; issued warrant for 50,000 shares at $1.20 exercise price.
- Registration rights agreement requires resale registration statement filed by Aug 30, 2024; effectiveness within 30 days.
- Yorkville ownership limited to 4.99%; aggregate issuance capped at 4,767,616 shares without shareholder approval.

## SEC filing metadata
- accession: 0001493152-24-024802
- form_type: 8-K
- ticker: ONMD
- cik: 0001849380
- company_name: OneMedNet Corp
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/0001493152-24-024802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024802
- JSON: https://secwatch.observer/filing/0001493152-24-024802.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.